BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.

Manufacturer adverse-event records for BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.… come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.

FDA MAUDE device safety record · 2014–2026 · thin-book · typical Death-code · injury-light

Volume signature

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.… is a thinner MAUDE footprint

BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. accounts for 4,386 FDA MAUDE reports (#400 of 434, thin-book tercile). Death-coded event_type share is 0.14% (typical); Injury share 5.1% (injury-light).

What the volume reading shows for BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V.

The standout signal for BD INFUSION THERAPY SYSTEMS INC. S.A. DE C.V. is filing volume: 4,386 adverse-event reports in FDA MAUDE (#400 of 434, thin-book). Death-coded event_type share sits at 0.14% (typical).

As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.

Reports span 20 device types, led in this extract by Malfunction at 4,156 (94.8% of event_type total). Peak single-year volume reaches 719 reports across 13 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.

4,386
Total Reports
6
Event-type Death
224
Injury Reports
20
Device Types

Event Types

Malfunction 4,156 (94.8%)
Injury 224 (5.1%)
Death 6 (0.1%)

Patient Outcomes

FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.

2,462 (56.5%)
Other 1,750 (40.2%)
Required Intervention 122 (2.8%)
R 8 (0.2%)
Hospitalization 8 (0.2%)
Death 4 (0.1%)
O 2 (0.0%)
L 1 (0.0%)
Life Threatening 1 (0.0%)

Yearly Trend

14
2014: 1
15
2015: 15
16
2016: 63
17
2017: 210
18
2018: 464
19
2019: 719
20
2020: 467
21
2021: 453
22
2022: 546
23
2023: 373
24
2024: 391
25
2025: 341
26
2026: 343